"10.1371_journal.pbio.1000054","plos biology","2009-03-10T00:00:00Z","Emmanuel Martin; Emmanuel Treiner; Livine Duban; Lucia Guerri; Hélène Laude; Cécile Toly; Virginie Premel; Anne Devys; Ivan C Moura; Florence Tilloy; Stéphane Cherif; Gabriella Vera; Sylvain Latour; Claire Soudais; Olivier Lantz","Laboratoire dImmunologie, Institut Curie, Paris, France; INSERM U932, Institut Curie, Paris, France; Avenir INSERM U925, Faculté de Médecine, Amiens, France; Établissement Français du Sang (EFS), Nantes, France; INSERM, Unité 768, Hôpital Necker-Enfants Malades, Paris, France","EM, ET, LG, CS, and OL conceived and designed the experiments. EM, ET, LD, LG, HL, CT, VP, AD, ICM, FT, SC, GV, and CS performed the experiments. EM, ET, LD, LG, HL, CT, ICM, CS, and OL analyzed the data. SL and OL contributed reagents/materials/analysis tools. CS and OL wrote the paper.","OL laboratory has received funding from Innate-Pharma, which co-owns the filled patent for the 3C10 antibody. EM has received salary through this funding.","2009","03","Emmanuel Martin","EM",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
